- #ASCO26: Roche details narrow failure of breast cancer pill trialBack in March, Roche revealed that the breast cancer pill on which it had pinned billion-dollar sales expectations had failed in a pivotal Phase 3 trial. Data presented Tuesday at ASCO reveal ...Endpoints · 1mo ago↗ source
- Fulcrum ends sickle cell ambitions following regulatory feedback, will seek exitFulcrum Therapeutics is scrapping its sole clinical-stage medicine after feedback from the FDA that referenced a recently pulled cancer drug from Ipsen. Fulcrum had planned to enter a registratio…Endpoints · 1mo ago↗ source
- Cancer cases weigh down Abivax’s Phase 3 maintenance data in ulcerative colitisAbivax has proclaimed that its maintenance trial in ulcerative colitis delivered “landmark” results, and the drug's safety profile has previously been one of its main potential selling points. But…